Scholars Central

Conference abstractPublished 13 Oct 2016

Current state-of-the-art in antibiotics, antibiotic resistance and novel antibacterial strategies

Authors: Samir Kumar-Singh

University of Antwerp, Belgium

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The last years have been an exciting time for antimicrobials and microbiological research. Firstly, Antimicrobial Resistance (AMR) was in the spotlight and heavily discussed in worldwide conventions from the G7 summit to President Obama’s national action plan. Also there has been unprecedented investment in developing new antibacterial strategies, by the public (EC) and private sector, mainly in the EU and (increasingly) the USA. After a long hiatus, a new class of antimicrobials (teixobactin) was finally discovered. Alarmingly, however, we also observed emergence of novel AMR mechanisms to last line antibiotics such as colistin this year. Finally, some very interesting breakthroughs in the field of novel diagnostics and host biomarker discovery were made utilizing nanotechnology and proteomics. This keynote lecture will try to encapsulate the major findings in the field of microbiological research during he last year with respect to AMR, novel antibiotics, and diagnostics and host biomarker discovery.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Drug Metabolism & Toxicology
  • SubjectDiabetes & Endocrinology
  • SubjectPharmaceutical Sciences
  • SubjectToxicology
  • BylineArticles whose byline prints “Samir Kumar-Singh”